JOHANNESBURG, South Africa (AFP) — South Africa announced Monday it would shortly resume using Johnson & Johnson anti-Covid vaccines, two weeks after the jab was suspended to vet risks over blood clots. The vaccine will be included in South Africa’s much-delayed anti-Covid vaccination campaign from Wednesday after being given the green light by SAHPRA, the country’s health watchdog. “It has since been established there is a one in a million chance of getting the clot […]
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.